225 related articles for article (PubMed ID: 26503631)
21. Risk stratification of colon carcinogenesis through enhanced backscattering spectroscopy analysis of the uninvolved colonic mucosa.
Roy HK; Kim YL; Liu Y; Wali RK; Goldberg MJ; Turzhitsky V; Horwitz J; Backman V
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):961-8. PubMed ID: 16467111
[TBL] [Abstract][Full Text] [Related]
22. Genetics, inheritance and strategies for prevention in populations at high risk of colorectal cancer (CRC).
Burn J; Mathers J; Bishop DT
Recent Results Cancer Res; 2013; 191():157-83. PubMed ID: 22893205
[TBL] [Abstract][Full Text] [Related]
23. Aspirin and non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.
Farmer KC; Goulston K; Macrae F
Med J Aust; 1993 Nov; 159(10):649-50. PubMed ID: 8232006
[No Abstract] [Full Text] [Related]
24. Interactions between CYP2C9 and UGT1A6 polymorphisms and nonsteroidal anti-inflammatory drugs in colorectal cancer prevention.
Samowitz WS; Wolff RK; Curtin K; Sweeney C; Ma KN; Andersen K; Levin TR; Slattery ML
Clin Gastroenterol Hepatol; 2006 Jul; 4(7):894-901. PubMed ID: 16797247
[TBL] [Abstract][Full Text] [Related]
25. Preventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.
Ishikawa H; Wakabayashi K; Suzuki S; Mutoh M; Hirata K; Nakamura T; Takeyama I; Kawano A; Gondo N; Abe T; Tokudome S; Goto C; Matsuura N; Sakai T
Cancer Med; 2013 Feb; 2(1):50-6. PubMed ID: 24133627
[TBL] [Abstract][Full Text] [Related]
26. Rectal Optical Markers for In Vivo Risk Stratification of Premalignant Colorectal Lesions.
Radosevich AJ; Mutyal NN; Eshein A; Nguyen TQ; Gould B; Rogers JD; Goldberg MJ; Bianchi LK; Yen EF; Konda V; Rex DK; Van Dam J; Backman V; Roy HK
Clin Cancer Res; 2015 Oct; 21(19):4347-4355. PubMed ID: 25991816
[TBL] [Abstract][Full Text] [Related]
27. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
Chan AT; Tranah GJ; Giovannucci EL; Hunter DJ; Fuchs CS
J Natl Cancer Inst; 2005 Mar; 97(6):457-60. PubMed ID: 15770010
[TBL] [Abstract][Full Text] [Related]
28. Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial.
Burn J; Sheth H; Elliott F; Reed L; Macrae F; Mecklin JP; Möslein G; McRonald FE; Bertario L; Evans DG; Gerdes AM; Ho JWC; Lindblom A; Morrison PJ; Rashbass J; Ramesar R; Seppälä T; Thomas HJW; Pylvänäinen K; Borthwick GM; Mathers JC; Bishop DT;
Lancet; 2020 Jun; 395(10240):1855-1863. PubMed ID: 32534647
[TBL] [Abstract][Full Text] [Related]
29. Suppression of human colorectal mucosal prostaglandins: determining the lowest effective aspirin dose.
Ruffin MT; Krishnan K; Rock CL; Normolle D; Vaerten MA; Peters-Golden M; Crowell J; Kelloff G; Boland CR; Brenner DE
J Natl Cancer Inst; 1997 Aug; 89(15):1152-60. PubMed ID: 9262254
[TBL] [Abstract][Full Text] [Related]
30. Effect of chemoprevention by low-dose aspirin of new or recurrent colorectal adenomas in patients with Lynch syndrome (AAS-Lynch): study protocol for a multicenter, double-blind, placebo-controlled randomized controlled trial.
Soualy A; Deutsch D; Benallaoua M; Ait-Omar A; Mary F; Helfen S; Boubaya M; Levy V; Benamouzig R;
Trials; 2020 Sep; 21(1):764. PubMed ID: 32887653
[TBL] [Abstract][Full Text] [Related]
31. Effects of piroxicam on prostaglandin E2 levels in rectal mucosa of adenomatous polyp patients: a randomized phase IIb trial.
Calaluce R; Earnest DL; Heddens D; Einspahr JG; Roe D; Bogert CL; Marshall JR; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1287-92. PubMed ID: 11142413
[TBL] [Abstract][Full Text] [Related]
32. Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.
Fink SP; Dawson DM; Zhang Y; Kresak A; Lawrence EG; Yang P; Chen Y; Barnholtz-Sloan JS; Willis JE; Kopelovich L; Markowitz SD
Carcinogenesis; 2015 Feb; 36(2):291-8. PubMed ID: 25503930
[TBL] [Abstract][Full Text] [Related]
33. Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans.
August DA; Landau J; Caputo D; Hong J; Lee MJ; Yang CS
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):709-13. PubMed ID: 10744131
[TBL] [Abstract][Full Text] [Related]
34. Metabolomics Analysis of Aspirin's Effects in Human Colon Tissue and Associations with Adenoma Risk.
Barry EL; Fedirko V; Uppal K; Ma C; Liu K; Mott LA; Peacock JL; Passarelli MN; Baron JA; Jones DP
Cancer Prev Res (Phila); 2020 Oct; 13(10):863-876. PubMed ID: 32655007
[TBL] [Abstract][Full Text] [Related]
35. Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Taha AS; McCloskey C; McSkimming P; McConnachie A
Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):469-476. PubMed ID: 29754836
[TBL] [Abstract][Full Text] [Related]
36. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients.
Sinicrope FA; Half E; Morris JS; Lynch PM; Morrow JD; Levin B; Hawk ET; Cohen DS; Ayers GD; Stephens LC;
Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):920-7. PubMed ID: 15184247
[TBL] [Abstract][Full Text] [Related]
37. Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.
Hull MA; Sprange K; Hepburn T; Tan W; Shafayat A; Rees CJ; Clifford G; Logan RF; Loadman PM; Williams EA; Whitham D; Montgomery AA;
Lancet; 2018 Dec; 392(10164):2583-2594. PubMed ID: 30466866
[TBL] [Abstract][Full Text] [Related]
38. ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.
Drew DA; Chin SM; Gilpin KK; Parziale M; Pond E; Schuck MM; Stewart K; Flagg M; Rawlings CA; Backman V; Carolan PJ; Chung DC; Colizzo FP; Freedman M; Gala M; Garber JJ; Huttenhower C; Kedrin D; Khalili H; Kwon DS; Markowitz SD; Milne GL; Nishioka NS; Richter JM; Roy HK; Staller K; Wang M; Chan AT
Trials; 2017 Feb; 18(1):50. PubMed ID: 28143522
[TBL] [Abstract][Full Text] [Related]
39. Effects of fish oil on rectal cell proliferation, mucosal fatty acids, and prostaglandin E2 release in healthy subjects.
Bartram HP; Gostner A; Scheppach W; Reddy BS; Rao CV; Dusel G; Richter F; Richter A; Kasper H
Gastroenterology; 1993 Nov; 105(5):1317-22. PubMed ID: 8224635
[TBL] [Abstract][Full Text] [Related]
40. The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
Petrera M; Paleari L; Clavarezza M; Puntoni M; Caviglia S; Briata IM; Oppezzi M; Mislej EM; Stabuc B; Gnant M; Bachleitner-Hofmann T; Roth W; Scherer D; Haefeli WE; Ulrich CM; DeCensi A
BMC Cancer; 2018 Dec; 18(1):1210. PubMed ID: 30514262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
